Medtronic, Inc. (MDT) Earnings Likely to Hinge on FY23 Guidance, BofA Securities Expects Y/Y Declines
Tweet Send to a Friend
BofA Securities analyst Travis Steed reiterated a Buy rating and $135.00 price target on Medtronic, Inc. (NYSE: MDT) ahead of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
